Search research articles
Contact Us
Filters
Showing results (151-160 of 181) with videos related to
Page
of 19
Sort By:
Antiviral Research
|
November 7, 2016
Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems
Stephen R Welch, Lisa Wiggleton Guerrero, Ayan K Chakrabarti, et al.
The Journal of Urology
|
November 1, 1996
Practice trends of American urologists in the treatment of impotence, incontinence and infertility
W F Gee, H L Holtgrewe, P C Albertsen, et al.
Antimicrobial Agents and Chemotherapy
|
December 22, 1999
Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1
G M Szczech, P Furman, G R Painter, et al.
Antiviral Research
|
May 1, 1996
DNA polymerase activity of hepatitis B virus particles: differential inhibition by L-enantiomers of nucleotide analogs
M G Davis, J E Wilson, N A VanDraanen, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1994
Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model
L D Condreay, R W Jansen, T F Powdrill, et al.
Mbio
|
September 12, 2025
Effective treatment of advanced Oropouche virus, Rift Valley fever virus, and Dabie bandavirus infections with 4'-fluorouridine
Jonna B Westover, Kie Hoon Jung, Inioska Rojas, et al.
Journal of Virology
|
November 24, 2017
β-d-<i>N</i><sup>4</sup>-Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome
Nadya Urakova, Valeriya Kuznetsova, David K Crossman, et al.
Antiviral Research
|
November 15, 2022
The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N<sup>4</sup>-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection
Gregory R Bluemling, Shuli Mao, Michael G Natchus, et al.
Biorxiv : the Preprint Server for Biology
|
February 16, 2022
SARS-CoV-2 variant of concern type and biological sex affect efficacy of molnupiravir in dwarf hamster model of severe COVID-19
Carolin M Lieber, Robert M Cox, Julien Sourimant, et al.
Antimicrobial Agents and Chemotherapy
|
December 20, 2000
Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine
P A Furman, J Jeffrey, L L Kiefer, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 181) with videos related to
Sort By:
Page
of 19
Antiviral Research
|
November 7, 2016
Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems
Stephen R Welch, Lisa Wiggleton Guerrero, Ayan K Chakrabarti, et al.
The Journal of Urology
|
November 1, 1996
Practice trends of American urologists in the treatment of impotence, incontinence and infertility
W F Gee, H L Holtgrewe, P C Albertsen, et al.
Antimicrobial Agents and Chemotherapy
|
December 22, 1999
Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1
G M Szczech, P Furman, G R Painter, et al.
Antiviral Research
|
May 1, 1996
DNA polymerase activity of hepatitis B virus particles: differential inhibition by L-enantiomers of nucleotide analogs
M G Davis, J E Wilson, N A VanDraanen, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1994
Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model
L D Condreay, R W Jansen, T F Powdrill, et al.
Mbio
|
September 12, 2025
Effective treatment of advanced Oropouche virus, Rift Valley fever virus, and Dabie bandavirus infections with 4'-fluorouridine
Jonna B Westover, Kie Hoon Jung, Inioska Rojas, et al.
Journal of Virology
|
November 24, 2017
β-d-<i>N</i><sup>4</sup>-Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome
Nadya Urakova, Valeriya Kuznetsova, David K Crossman, et al.
Antiviral Research
|
November 15, 2022
The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N<sup>4</sup>-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection
Gregory R Bluemling, Shuli Mao, Michael G Natchus, et al.
Biorxiv : the Preprint Server for Biology
|
February 16, 2022
SARS-CoV-2 variant of concern type and biological sex affect efficacy of molnupiravir in dwarf hamster model of severe COVID-19
Carolin M Lieber, Robert M Cox, Julien Sourimant, et al.
Antimicrobial Agents and Chemotherapy
|
December 20, 2000
Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine
P A Furman, J Jeffrey, L L Kiefer, et al.
Page
of 19